Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Ahn-Gook Pharmaceuticals Co.,Ltd

Clinicaltrial registered30 Oct 2026

Ahn-Gook Pharmaceuticals Co.,Ltd

30 Oct 2026: Trial registered · A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
30 Oct 2026
Title
A Study to Evaluate the Effectiveness and Safety of S-amlodipine-based Monotherapy and Combination Therapy
Conditions
Hypertension (HTN), Hypertension, Essential (Primary) Hypertension
Study Type
Observational
Status
Not Yet Recruiting
Reference
NCT07907822
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Ahn-Gook Pharmaceuticals Co.,Ltd

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.